Cary Street Partners Financial LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cary Street Partners Financial LLC
- $3.16 Trillion
- Q1 2025
A detailed history of Cary Street Partners Financial LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 255 shares of REGN stock, worth $154,178. This represents 0.01% of its overall portfolio holdings.
Number of Shares
255
Previous 1,214
79.0%
Holding current value
$154,178
Previous $865 Million
81.32%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,469Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.69 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.11 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.42 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.9 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.41 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...